INSTITUTO FINLAY DE VACUNAS

Trials shown by sponsor

Public title	Date of Registration	State
SOBERANA 02-FaseIII	03/03/2021	Registered
Study on pneunococcal vaccination in the pediatric population from 1 year to 5 years	03/08/2023	Registered
Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana	04/10/2023	Registered
Study of the meningococcal ACW135 polysaccharide vaccine	04/12/2015	Registered
SOBERANA 01B	05/01/2021	Registered
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 .	06/11/2014	Registered
SOBERANA PLUS	09/04/2021	Registered
SOBERANA PEDIATRIA	10/06/2021	Registered
Randomized double blind controlled, phase I clinical trial, to assess safety, reactogenicity and immunogenicity of the 638 vaccine candidate, in healthy female and male children and adolescents aged from 5 to 17 years old from Cienfuegos Province, Cuba.	11/10/2013	Registered
SOBERANA PLUS TURIN	12/11/2021	Registered outdated
SOBERANA 01	13/08/2020	Registered outdated
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect)	13/10/2017	Registered outdated
SOBERANA 01A	17/10/2020	Registered
SOBERANA 02A	17/12/2020	Registered outdated
SOBERANA - INTERVENTION	19/03/2021	Registered
To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects	19/05/2023	Registered
Post marketing clinical trial to evaluate the reactogenicity profile of the Cuban vaccine against diphtheria, tetanus, and pertussis infections in infants.	2008-07-29	Registered
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers.	2008-07-29	Registered
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age.	2008-07-29	Registered
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET.	2008-07-29	Registered

Registered Trials

Registration process

INSTITUTO FINLAY DE VACUNAS

About the RPCEC

Useful resources